BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18086052)

  • 21. Comparison of 2 Fillers for Lip Injection-A Randomized-Controlled Clinical Trial Assessed by 3D Imaging.
    Germani M; Miranda de Souza Almeida CC; Muñoz-Lora VRM
    Aesthet Surg J Open Forum; 2024; 6():ojae003. PubMed ID: 38938925
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Faria GEL; Palo JS; Torres AR; Machado ACHR; Boggio RF
    Clin Cosmet Investig Dermatol; 2023; 16():2781-2791. PubMed ID: 37823019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal Reshaping with Hyaluronic Acid: An Alternative or Complement to Surgery.
    Hedén P
    Plast Reconstr Surg Glob Open; 2016 Nov; 4(11):e1120. PubMed ID: 27975025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Structured Approach for Treating Calcium Hydroxylapatite Focal Accumulations.
    McCarthy AD; van Loghem J; Martinez Ii KA; Aguilera SB; Funt D
    Aesthet Surg J; 2024 Feb; ():. PubMed ID: 38366791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.
    Moers-Carpi MM; Tufet JO
    Dermatol Surg; 2008 Feb; 34(2):210-5. PubMed ID: 18093199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler.
    Yutskovskaya Y; Kogan E; Leshunov E
    J Drugs Dermatol; 2014 Sep; 13(9):1047-52. PubMed ID: 25226004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results.
    Bass LS; Smith S; Busso M; McClaren M
    Aesthet Surg J; 2010 Mar; 30(2):235-8. PubMed ID: 20442101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, split-face, randomized, comparative study of safety and 12-month longevity of three formulations of hyaluronic acid dermal filler for treatment of nasolabial folds.
    Prager W; Wissmueller E; Havermann I; Bee EK; Howell DJ; Zschocke I; Simon J
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1143-50. PubMed ID: 22759250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid.
    Sundaram H; Voigts B; Beer K; Meland M
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1859-65. PubMed ID: 20969663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications.
    Sundaram H; Cassuto D
    Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):5S-21S. PubMed ID: 24077013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A blanching technique for intradermal injection of the hyaluronic acid Belotero.
    Micheels P; Sarazin D; Besse S; Sundaram H; Flynn TC
    Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):59S-68S. PubMed ID: 24077012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm injectable gel with and without lidocaine.
    Weinkle SH; Bank DE; Boyd CM; Gold MH; Thomas JA; Murphy DK
    J Cosmet Dermatol; 2009 Sep; 8(3):205-10. PubMed ID: 19735519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium hydroxylapatite for jawline rejuvenation: consensus recommendations.
    Dallara JM; Baspeyras M; Bui P; Cartier H; Charavel MH; Dumas L
    J Cosmet Dermatol; 2014 Mar; 13(1):3-14. PubMed ID: 24641600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo bio-integration of three hyaluronic acid fillers in human skin: a histological study.
    Tran C; Carraux P; Micheels P; Kaya G; Salomon D
    Dermatology; 2014; 228(1):47-54. PubMed ID: 24503674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of incobotulinumtoxinA for treatment of glabellar frown lines: a post hoc pooled analysis of 2 randomized, placebo-controlled, phase 3 trials.
    Jones D; Carruthers J; Narins RS; Coleman WP; Harrington L; Brandt FS; Cohen JL
    Dermatol Surg; 2014 Jul; 40(7):776-85. PubMed ID: 25111351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips.
    Philipp-Dormston WG; Hilton S; Nathan M
    J Cosmet Dermatol; 2014 Jun; 13(2):125-34. PubMed ID: 24910276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium hydroxyl-apatite (Radiesse) for the correction of periorbital hollows, dark circles, and lower eyelid bags.
    Bernardini FP; Cetinkaya A; Devoto MH; Zambelli A
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):34-9. PubMed ID: 24398484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.